Literature DB >> 8387437

Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells.

T Towata1, N Hayashi, K Katayama, T Takehara, E Miyoshi, Y Kawanishi, K Ueda, A Kasahara, H Fusamoto, T Kamada.   

Abstract

This study investigated the expression of HLA class I antigens on Huh6 and HB611 cells induced by interferon (IFN)-alpha, IFN-gamma, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. All of these cytokines induced the antigens on both cells in a dose-dependent manner, with IFNs inducing much more expression than TNF-alpha or IL-1 beta. We have already reported that protein kinase C (PKC) is involved in the antigen expression induced by IFN-gamma on Huh6 cells. The antigen expression induced by IFN-alpha was also blocked by a PKC inhibitor, H-7. However, the antigen expression by TNF-alpha or IL-1 beta was not inhibited by H-7, by a protein kinase A inhibitor, HA1004, nor by a calmodulin antagonist, W-7. These results suggested that PKC, Ca(2+)-calmodulin, and cAMP are not involved in the induction of HLA class I antigens on both cells by TNF-alpha and IL-1 beta. We concluded that TNF-alpha and IL-1 beta induced much less expression of HLA class I antigens on both cells than IFNs and that this might be because the signaling pathway by TNF-alpha and IL-1 beta differed from that by IFNs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387437     DOI: 10.1007/bf02779226

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  33 in total

Review 1.  The regulation and expression of MHC class I genes.

Authors:  B David-Watine; A Israël; P Kourilsky
Journal:  Immunol Today       Date:  1990-08

2.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.

Authors:  M Pignatelli; J Waters; D Brown; A Lever; S Iwarson; Z Schaff; R Gerety; H C Thomas
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

3.  Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.

Authors:  M Inoue; S Kakumu; K Yoshioka; Y Tsutsumi; T Wakita; M Arao
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

Authors:  N V Naumov; M Mondelli; G J Alexander; R S Tedder; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

5.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 6.  Calmodulin plays a pivotal role in cellular regulation.

Authors:  W Y Cheung
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

7.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

8.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease.

Authors:  A Fuji; S Kakumu; Y Ohtani; K Murase; H Hirofuji; H Tahara
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

10.  Enhanced expression of HLA class I by inhibited replication of hepatitis B virus.

Authors:  T Takehara; N Hayashi; K Katayama; K Ueda; T Towata; A Kasahara; H Fusamoto; T Kamada
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.